% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Duering:258919,
author = {Duering, Marco and Biessels, Geert Jan and Brodtmann, Amy
and Chen, Christopher and Cordonnier, Charlotte and de
Leeuw, Frank-Erik and Debette, Stéphanie and Frayne,
Richard and Jouvent, Eric and Rost, Natalia S and Ter
Telgte, Annemieke and Al-Shahi Salman, Rustam and Backes,
Walter H and Bae, Hee-Joon and Brown, Rosalind and Chabriat,
Hugues and De Luca, Alberto and deCarli, Charles and
Dewenter, Anna and Doubal, Fergus N and Ewers, Michael and
Field, Thalia S and Ganesh, Aravind and Greenberg, Steven
and Helmer, Karl G and Hilal, Saima and Jochems, Angela C C
and Jokinen, Hanna and Kuijf, Hugo and Lam, Bonnie Y K and
Lebenberg, Jessica and MacIntosh, Bradley J and Maillard,
Pauline and Mok, Vincent C T and Pantoni, Leonardo and
Rudilosso, Salvatore and Satizabal, Claudia L and Schirmer,
Markus D and Schmidt, Reinhold and Smith, Colin and Staals,
Julie and Thrippleton, Michael J and van Veluw, Susanne J
and Vemuri, Prashanthi and Wang, Yilong and Werring, David
and Zedde, Marialuisa and Akinyemi, Rufus O and Del Brutto,
Oscar H and Markus, Hugh S and Zhu, Yi-Cheng and Smith, Eric
E and Dichgans, Martin and Wardlaw, Joanna M},
title = {{N}euroimaging standards for research into small vessel
disease-advances since 2013.},
journal = {The lancet / Neurology},
volume = {22},
number = {7},
issn = {1474-4422},
address = {London},
publisher = {Lancet Publ. Group},
reportid = {DZNE-2023-00691},
pages = {602 - 618},
year = {2023},
abstract = {Cerebral small vessel disease (SVD) is common during ageing
and can present as stroke, cognitive decline,
neurobehavioural symptoms, or functional impairment. SVD
frequently coexists with neurodegenerative disease, and can
exacerbate cognitive and other symptoms and affect
activities of daily living. Standards for Reporting Vascular
Changes on Neuroimaging 1 (STRIVE-1) categorised and
standardised the diverse features of SVD that are visible on
structural MRI. Since then, new information on these
established SVD markers and novel MRI sequences and imaging
features have emerged. As the effect of combined SVD imaging
features becomes clearer, a key role for quantitative
imaging biomarkers to determine sub-visible tissue damage,
subtle abnormalities visible at high-field strength MRI, and
lesion-symptom patterns, is also apparent. Together with
rapidly emerging machine learning methods, these metrics can
more comprehensively capture the effect of SVD on the brain
than the structural MRI features alone and serve as
intermediary outcomes in clinical trials and future routine
practice. Using a similar approach to that adopted in
STRIVE-1, we updated the guidance on neuroimaging of
vascular changes in studies of ageing and neurodegeneration
to create STRIVE-2.},
subtyp = {Review Article},
keywords = {Humans / Neurodegenerative Diseases / Activities of Daily
Living / Neuroimaging / Magnetic Resonance Imaging: methods
/ Brain: diagnostic imaging / Cognitive Dysfunction /
Cerebral Small Vessel Diseases: diagnostic imaging},
cin = {AG Dichgans},
ddc = {610},
cid = {I:(DE-2719)5000022},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37236211},
doi = {10.1016/S1474-4422(23)00131-X},
url = {https://pub.dzne.de/record/258919},
}